2024-04-01 SC574142 2025-03-31 SC574142 2024-04-01 2025-03-31 SC574142 2024-03-31 SC574142 2023-04-01 2024-03-31 SC574142 uk-core:WithinOneYear 2024-03-31 SC574142 uk-core:WithinOneYear 2025-03-31 SC574142 uk-core:ShareCapital 2025-03-31 SC574142 uk-core:ShareCapital 2024-03-31 SC574142 uk-core:RetainedEarningsAccumulatedLosses 2025-03-31 SC574142 uk-core:RetainedEarningsAccumulatedLosses 2024-03-31 SC574142 uk-bus:Director1 2024-04-01 2025-03-31 SC574142 uk-core:ComputerEquipment 2024-04-01 2025-03-31 SC574142 uk-core:AfterOneYear 2025-03-31 SC574142 uk-core:AfterOneYear 2024-03-31 SC574142 uk-core:WithinOneYear 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure SC574142 uk-bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 SC574142 uk-bus:FRS102 2024-04-01 2025-03-31 SC574142 uk-bus:FilletedAccounts 2024-04-01 2025-03-31 SC574142 uk-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31
JBMC Respiratory Limited
Registered Number:SC574142
For the year ended 31 March 2025
Scotland
Unaudited Financial Statements
2
For the year ended 31 March 2025
JBMC Respiratory Limited
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
3
Registered Number :
SC574142
As at 31 March 2025
JBMC Respiratory Limited
Statement of Financial Position
£
£
2024
2025
Notes
Fixed assets
Property, plant and equipment
1,435
-
2
1,435
-
Current assets
Trade and other receivables
57,000
29,352
3
13,657
Cash and cash equivalents
53,977
83,329
70,657
Trade and other payables: amounts falling due within one
year
(14,237)
(11,974)
4
56,420
71,355
Net current assets
Total assets less current liabilities
72,790
56,420
72,790
Net assets
56,420
Capital and reserves
Called up share capital
1
1
Retained earnings
72,789
56,419
72,790
56,420
Shareholders' funds
For the year ended 31 March 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
John McCafferty Director
These financial statements were approved and authorised for issue by the Board on 28 November 2025 and were signed by:
The notes form part of these financial statements
1 of 3
4
For the year ended 31 March 2025
JBMC Respiratory Limited
Notes to the Financial Statements
Statutory Information
JBMC Respiratory Limited is a private limited company, limited by shares, domiciled in Scotland, registration number
SC574142.
Registered address:
2 Ventnor Terrace
Edinburgh
EH9 2BW
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial
Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the
Companies Act 2006. The financial statements have been prepared under the historical costs convention as
modified by the revaluation of certain assets.
Property, plant and equipment
Property, plant and equipment, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
20% Reducing balance
Computer Equipment
2. Property, plant and equipment
Computer
Equipment
£
Cost or
valuation
1,794
Additions
At 31 March 2025
1,794
Provision for depreciation and impairment
Charge for year
359
At 31 March 2025
359
At 31 March 2025
Net book value
1,435
2 of 3
5
For the year ended 31 March 2025
JBMC Respiratory Limited
Notes to the Financial Statements Continued
3. Trade and other receivables
2024
2025
£
£
Other debtors
29,352
57,000
The debtors above include the following amounts falling due after more than one year:
Other debtors
29,352
57,000
Short-term debtors are measured at fair value at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and measured subsequently at amortised cost using the effective interest method, less any impairment.
4. Trade and other payables: amounts falling due within one year
2024
2025
£
£
Taxation and social security
3,715
7,691
Other creditors
8,259
6,546
11,974
14,237
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
5. Average number of persons employed
During the year the average number of employees was 1 (2024 : 1)
3 of 3